MoneyShow's Best Investment Ideas For 2024: Part 3

Jan. 29, 2024 10:45 AM ET, , , , , , , , , , , ,
MoneyShow
2.07K Followers

Summary

  • MoneyShow presents top investment ideas for 2024 from their contributors.
  • This year’s edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth stocks, as well as ETF recommendations that target commodities, cryptocurrencies, and fixed income.
  • Part 3 of this series includes Celldex Therapeutics, Charles Schwab, Corning, CTO Realty Growth and Cullen/Frost Bankers, among others.

2024 with target board and arrow on wooden block cube for preparation new year change and start new business target strategy concept.

Dilok Klaisataporn/iStock via Getty Images

MoneyShow’s top contributing analysts, strategists, and newsletter editors share their investment recommendations for the year ahead. See Part 2 here.

Celldex Therapeutics

By John McCamant, Editor of The Medical Technology Stock Letter

Celldex Therapeutics

This article was written by

2.07K Followers
MoneyShow — an industry pioneer in investor education since 1981 — is a global, financial media company, operating the world's leading investment and trading conferences. Each show brings together thousands of investors to attend workshops, presentations and seminars given by the nation's top financial experts. The company also offers exclusive seminars-at-sea, with the investment industry's leading partners. In addition, MoneyShow operates the award-winning, multimedia online community, Moneyshow.com and publishes free Investing and Trading newsletters, which provide individual investors with exclusive ongoing access to the latest investment and trading ideas from the nation's most respected and trusted financial newsletter advisors.

Recommended For You

Related Stocks

SymbolLast Price% Chg
CLDX--
Celldex Therapeutics, Inc.
LEU--
Centrus Energy Corp.
SCHW--
The Charles Schwab Corporation
CHRD--
Chord Energy Corporation
CNH--
CNH Industrial N.V.

Related Analysis